Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,309 | 408 | 98.9% |
| Education | $69.48 | 6 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,226 | 87 | $0 (2024) |
| Novo Nordisk Inc | $821.50 | 57 | $0 (2024) |
| Radius Health, Inc. | $503.65 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $440.83 | 26 | $0 (2024) |
| Lilly USA, LLC | $376.73 | 27 | $0 (2023) |
| PFIZER INC. | $299.60 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $286.15 | 16 | $0 (2022) |
| GlaxoSmithKline, LLC. | $160.27 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $158.76 | 9 | $0 (2023) |
| Merck Sharp & Dohme LLC | $129.13 | 10 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $534.12 | 32 | Amgen Inc. ($140.16) |
| 2023 | $415.06 | 23 | Radius Health, Inc. ($83.93) |
| 2022 | $765.40 | 42 | Amgen Inc. ($149.92) |
| 2021 | $846.30 | 53 | Novo Nordisk Inc ($169.44) |
| 2020 | $672.27 | 41 | AstraZeneca Pharmaceuticals LP ($111.65) |
| 2019 | $975.80 | 58 | Amgen Inc. ($371.95) |
| 2018 | $958.55 | 78 | Amgen Inc. ($179.20) |
| 2017 | $1,211 | 87 | Lilly USA, LLC ($208.67) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Inflammation | ||||||
| 11/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $4.23 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.23 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/09/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Bone Health | ||||||
| 10/01/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: VACCINES | ||||||
| 09/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.18 | General |
| Category: Inflammation | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.78 | General |
| Category: Bone Health | ||||||
| 08/21/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Endocrinology | ||||||
| 08/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.31 | General |
| Category: Inflammation | ||||||
| 07/29/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $5.16 | General |
| Category: Inflammation/Rare Disease | ||||||
| 07/26/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Endocrinology | ||||||
| 07/23/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Medical Device | ||||||
| 06/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: Inflammation | ||||||
| 05/29/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Psychology/Psychiatric | ||||||
| 05/28/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Bone Health | ||||||
| 05/23/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: Endocrinology | ||||||
| 05/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Cardiology | ||||||
| 05/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: Diabetes Care | ||||||
| 04/24/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $27.90 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,921 | 13,463 | $608,157 | $420,759 |
| 2022 | 35 | 2,901 | 13,341 | $563,010 | $417,893 |
| 2021 | 34 | 2,735 | 14,041 | $546,299 | $404,367 |
| 2020 | 35 | 2,884 | 14,864 | $532,399 | $400,905 |
All Medicare Procedures & Services
130 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 94 | 9,661 | $242,065 | $175,577 | 72.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 493 | 921 | $157,397 | $85,265 | 54.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 429 | 429 | $59,458 | $56,227 | 94.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 282 | 400 | $47,450 | $23,055 | 48.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 182 | 187 | $13,377 | $13,035 | 97.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 40 | 46 | $13,528 | $9,897 | 73.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 425 | 425 | $8,313 | $8,006 | 96.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 162 | 163 | $6,586 | $6,314 | 95.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 30 | 35 | $7,570 | $5,723 | 75.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 182 | 187 | $5,826 | $5,669 | 97.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $5,301 | $5,184 | 97.8% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 11 | 84 | $5,517 | $3,793 | 68.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 28 | 29 | $5,435 | $3,688 | 67.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 66 | 79 | $6,715 | $2,700 | 40.2% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 26 | 71 | $3,049 | $2,358 | 77.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 107 | 205 | $3,125 | $2,341 | 74.9% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 63 | 146 | $2,443 | $2,336 | 95.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 45 | 52 | $3,087 | $1,815 | 58.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $3,002 | $1,685 | 56.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 32 | 99 | $2,415 | $1,662 | 68.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 31 | 34 | $1,881 | $1,318 | 70.1% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 19 | $1,752 | $1,055 | 60.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $960.00 | $750.72 | 78.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 12 | 12 | $1,077 | $742.50 | 68.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 35 | $617.05 | $367.04 | 59.5% |
About Dr. S Janel Beatie, MD
Dr. S Janel Beatie, MD is a Internal Medicine healthcare provider based in Tomball, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801982020.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. S Janel Beatie, MD has received a total of $6,378 in payments from pharmaceutical and medical device companies, with $534.12 received in 2024. These payments were reported across 414 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($6,309).
As a Medicare-enrolled provider, Beatie has provided services to 11,441 Medicare beneficiaries, totaling 55,709 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 130 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Tomball, TX
- Active Since 10/05/2006
- Last Updated 07/16/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1801982020
Products in Payments
- EVENITY (Biological) $425.06
- Ozempic (Drug) $331.26
- Tymlos (Biological) $320.20
- Prolia (Biological) $319.11
- FARXIGA (Drug) $306.38
- Aimovig (Biological) $264.73
- XARELTO (Drug) $225.63
- Tymlos (Drug) $183.45
- TRULICITY (Drug) $172.31
- Victoza (Drug) $166.71
- CONTRAVE (Drug) $158.61
- ENTRESTO (Drug) $143.79
- FORTEO (Drug) $123.65
- RYBELSUS (Drug) $120.26
- Vascepa (Drug) $104.59
- SYNTHROID (Drug) $99.51
- XIFAXAN (Drug) $98.92
- Otezla (Drug) $98.37
- PREVNAR - 13 (Biological) $97.47
- Tresiba (Drug) $80.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tomball
Muhammad Irfan, M.d, M.D
Internal Medicine — Payments: $56,330
Shamaila Aslam, Md, MD
Internal Medicine — Payments: $23,675
Muhammad Motiwala, Md, MD
Internal Medicine — Payments: $11,194
Imran Nathani, Md, MD
Internal Medicine — Payments: $10,265
Dr. Mark Le, M.d, M.D
Internal Medicine — Payments: $7,042
Amanbir Sohal, M.d, M.D
Internal Medicine — Payments: $6,139